MedTrace Logo

IgG-4 Levels in Systemic Sclerosis

NCT04219592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2025-05-16

No results posted yet for this study

Summary

This is an observational - non interventional study. The investigators will compare IgG4 levels of 80 healthy donors (from Israel blood bank - MDA) and 80 Systemic Sclerosis patients from Meir Medical Center.

Conditions

Interventions

DIAGNOSTIC_TEST

IgG4 measurement (non-interventional, just obtaining data from medical records)

IgG4 measurement in mg/dL

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-30
Primary Completion
2024-09-30
Completion
2024-10-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04219592 on ClinicalTrials.gov